NCT02574754View on ClinicalTrials.gov

Assessment of 2012 Bioequivalence Standards for Warfarin

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Healthy
Interventions
DRUG

warfarin

warfarin 10 mg PO x 1

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02574754 - Assessment of 2012 Bioequivalence Standards for Warfarin | Biotech Hunter | Biotech Hunter